This is a list of the Review Group members. Click on their names for individual biographies.

Professor Dame Ann Dowling DBE FREng FRS

Professor Sir John Bell GBE HonFREng FRS FMedSci

Professor Tim Besley CBE FBA

Mr Paul Clarke

Professor Richard Clegg

Mr David Eyton FREng

Dr Phil George

Dr Dave Hughes

Professor Graham Hutchings FRS FLSW

Dr Melanie Lee CBE FMedSci

Professor John McCanny CBE FREng FRS

Professor Sir Jim McDonald FREng FRSE

Dr Ruth McKernan CBE

Professor Ric Parker CBE FREng

Mr Nigel Perry FREng

Dr Mark Taylor

Professor Jeremy Watson CBE FREng

back to top 

Professor Sir John Bell GBE HonFREng FRS FMedSci

Professor Sir John Bell GBE HonFREng FRS FMedSci is Regius Professor of Medicine at Oxford University, and Chairman of the Office for the Strategic Coordination of Health Research.  He served as President of the Academy of Medical Sciences from 2006 to 2011.  As a Rhodes Scholar (1975-78), Sir John undertook his medical training in the UK and then went on to Stanford University, returning to the UK in 1987.  His research interests are in the area of autoimmune disease and immunology where he has contributed to the understanding of immune activation in a range of autoimmune diseases. 

In 1993, he founded the Wellcome Trust Centre for Human Genetics, one of the world’s leading centres for complex trait common disease genetics.  In 2001, he was appointed non-executive director of Roche Holding AG and in 2008 he joined the Gates Foundation Global Health Advisory Board which he has chaired since 2012.  Sir John was responsible for the working party that produced the highly influential Academy of Medical Sciences Strengthening Clinical Research report that highlighted the need for the UK to focus some of its attention on developing expertise in translational research.  In December 2011, Sir John was appointed one of two UK Life Sciences Champions by the Prime Minister.  He sits on the board of Genome England Limited and chairs its Science Advisory Committee. 

He was appointed Knight Grand Cross of the Order of the British Empire (GBE) in the 2015 New Year Honours for services to medicine, medical research and the life science industry.

back to top 

Professor Tim Besley CBE FBA

Tim Besley CBE FBA is School Professor of Economics and Political Science at the London School of Economics and Political Science (LSE). He is also a Visiting Professor at the Institute for International Economic Studies at Stockholm University.

From 2006 to 2009, he served as an external member of the Bank of England Monetary Policy Committee. He also serves as a Research Fellow at the Institute for Fiscal Studies and is a program member of the Institutions, Organizations and Growth Program of the Canadian Institute for Advanced Research (CIFAR).

Professor Besley is the 2005 winner of the Yrjö Jahnsson Award of the European Economics Association which is granted every other year to an economist aged under 45 who has made a significant contribution to economics in Europe. His research, which mostly has a policy focus, is mainly in the areas of Development Economics, Public Economics and Political Economy.

back to top 

Mr Paul Clarke

Paul Clarke is Director of Technology at Ocado, the world's largest online-only grocery retailer.

After joining Ocado in 2006, Paul initially worked on warehouse control systems and then joined the team designing Ocado’s next highly automated fulfilment centre. After establishing new teams for Simulation and Mobile development, Paul then co-wrote the first of Ocado’s award winning mobile apps which remain the only apps from a major retailer supporting full offline shopping. In his current role, Paul heads up Ocado Techology, whose 650+ software engineers and other IT specialists are responsible for building all the software and IT infrastructure that powers Ocado.

After graduating in Physics from Oxford in 1980, Paul joined the computer consultancy Scicon.  In 1983, Paul co-founded Torus Systems which developed an iconic WIMP style environment for the newly launched IBM PC and which was subsequently adopted by IBM as the network operating system for its Token Ring network. Since then he has spent most of his career working either as a freelance consultant or in technology startup ventures. Paul lives with his wife, three children, three cats and dog in North London.

back to top 

Professor Richard Clegg

Professor Clegg has 30 years nuclear background in industry, government and academia in the civil and defence sectors.

He is currently MD for Lloyd’s Register Foundation; shareholder of the LR Group and one of largest charitable foundations in UK in terms of revenue, focussed on engineering science, research and education.

Professor Clegg's previous roles include Global Nuclear Director, Lloyd’s Register; MD, UK National Nuclear Centre of Excellence; Chief Scientist, UK Atomic Weapons Establishment; Professor and Director of Dalton Nuclear Institute and Faculty Research Dean, The University of Manchester; and Group Science Director British Nuclear Fuels.

Professor Clegg's technical background is in radiation chemistry and environmental modelling.

He is also a member of the Nuclear Advisory Board to UK Government on UK nuclear strategy and roadmap.

back to top 

Mr David Eyton FREng

As Head of Technology, David Eyton is accountable for technology strategy and its implementation across BP, and conducting research and development in areas of corporate renewal.  In this role, David sits on the UK Energy Technologies Institute Board.

Prior to this, David was BP’s Exploration and Production (E&P) Group Vice President for Technology.  In this role, David was responsible for research and development, technical service work, digital and communications technology, and procurement and supply chain management for BP’s upstream business.

David joined BP in 1982 from Cambridge University with an engineering degree.   During his early career, he held a number of petroleum engineering, commercial and business management positions.   In 1996, he was named General Manager of BP’s North West Shelf interest in Australia.  David later managed Wytch Farm in the UK and then BP’s Gas Businesses in Trinidad.  Following that assignment, David was Vice President of Deepwater Developments in the Gulf of Mexico.

David is a fellow of the UK Royal Academy of Engineering, Institute of Materials, Minerals & Mining and Institute of Directors.

back to top 

Dr Phil George

Phil George is founder and Creative Director of the Cardiff-based television production company Green Bay Media which specialises in high-end documentary projects for broadcasters in Wales, the UK networks and internationally. The company has won numerous awards at BAFTA and the Celtic Film and Television Festival.

Notable productions in recent times include the six-hour series The Story of Wales with Huw Edwards; the three-part BBC Four series on Shakespeare, The King and the Playwright, with Professor James Shapiro; and major international projects such as three series on ecological and cultural change in great landscapes (Rivers, Islands and Deserts).

Previously, Phil was Head of Arts Music and Features at BBC Wales and an award-winning executive producer of series such as Michael Ignatieff’s Blood and Belonging about resurgent nationalism in the 1990s.

Phil’s industry and public affairs activities include his roles as founding Chair of National Theatre Wales and Chair of the Creative Economy Advisory Board at Cardiff University. He sits on the Steering Committee of the REACT Hub of universities in the West of England and Wales, which funds collaborations between arts and humanities researchers and creative companies. He was a REF Impact Assessor in 2014.

A proud son of the Rhondda Valley, Phil was educated there and at Christ Church Oxford. He has an honorary doctorate from the University of South Wales and in 2011 received the Inspire Wales award for his work at National Theatre Wales and Green Bay.

back to top 

Dr Dave Hughes

Dave Hughes is a synthetic organic chemist by training. After finishing a postdoctoral position in the USA, he returned to the UK to join the agrochemical industry as a chemistry team leader, designing and synthesizing new potential pesticides. After ten years, he moved to head a biochemistry and genetics group investigating the mode of action of pesticides. Five years later, Dave moved to a role in external collaborations, and is now global head of technology scouting for Syngenta: responsible for seeking out strategic relationships with universities and other companies around the globe in order to collaborate and co-develop new technologies for use in agriculture.

back to top 

Professor Graham Hutchings FRS FLSW

Graham Hutchings, born 1951, studied chemistry at University College London. His early career was with ICI and AECI Ltd, where he became interested in gold catalysis. In 1984, he moved to academia and has held chairs at the Universities of Witwatersrand, Liverpool and Cardiff, and currently he is Director of the Cardiff Catalysis Institute. He was elected a Fellow of the Royal Society in 2009, and he was awarded the Davy Medal of the Royal Society in 2013.

back to top 

Dr Melanie Lee CBE FMedSci

Melanie’s academic grounding in molecular genetics involved three complex systems of DNA repair, recombination and cell cycle control.  Melanie was cited by Sir Paul Nurse, FRS, in his inaugural ceremony in Stockholm on receipt of his Nobel Prize for Medicine in 2001 for her contribution to his cell cycle work. Melanie’s industrial career has been in research through Glaxo and GlaxoWellcome, leading R&D at Celltech/UCB, and as CEO of Syntaxin and NightstaRx.

During the R&D appointments, Melanie has led R&D teams and managed portfolios across a broad range of therapeutic programmes and therapeutic modalities, from inflammation to neurology and small molecules to biologics.  During her six years at Celltech plc, she was a FTSE 100 Board Director and spent five years on the Executive Committee of UCB.  During these 11 years, Melanie led R&D through six major mergers and integrations.

Melanie became CEO of venture-backed Syntaxin on 2010, which was sold to Ipsen in 2013 and she founded NightstaRx, a Syncona, Wellcome Trust company in 2014.  Melanie transitioned to the Board of NightstaRx at the end of 2014 to take the role of Chief Scientific officer for BTGplc, where she is a member of the Leadership Team from January 2015.

Melanie joined the Boards of BTGplc in November 2010 and Lundbeck SA in March 2012. She resigned from the BTGplc board in September 2014 to accept the role of CSO with BTGplc.

Melanie was the Chair of Cancer Research Technology (CRT) and on the Board of CRT for 10 years until September 2011 and she was a Trustee and Deputy Chair of Cancer Research UK for six years. Melanie was honoured in 2008 with a CBE for services to Medical Science.  She is a Council Member for the Academy of Medical Sciences and a supporter of initiatives to provide young scientists in the UK with opportunities for strong industrial careers.

back to top 

Professor John McCanny CBE FREng FRS

Professor John McCanny is an international authority on special purpose silicon architectures for Signal and Video Processing and for Cryptography. He is a Fellow of the Royal Society, the Royal Academy of Engineering, the Irish Academy of Engineering, the Institute of Electrical and Electronic Engineers (IEEE), the Institution of Engineering and Technology (IET), the Institute of Physics, and Engineers Ireland. He is also a Member of the Royal Irish Academy.

His honours and awards include a UK Royal Academy of Engineering Silver Medal (1996), an IEEE Millennium Medal, the Royal Dublin Society/Irish Times Boyle medal (2004), the IET’s Faraday medal (2006 - its highest honour) and the Royal Irish Academy’s Cunningham medal (2011 - its highest honour).

He has co-founded two successful high technology companies based on the work of his research teams, Amphion Semiconductor Ltd. – later acquired by Conexant, then NXP, then Entropic - and Audio Processing Technology Ltd - acquired in 2011 by Cambridge Silicon Radio.

Amphion was founded to licence complex silicon chip designs digital TV and multimedia applications with customers including Intel, Sony, Microsoft and Panasonic. Around one third of the Set-Top-Box video decoding chips worldwide now incorporate its technology with over 150 million having been fabricated. APT’s aptX hi-fi audio compression products were used as the basis for Digital Theatre Sound (DTS) first used in movies such as Jurassic Park and Schindler’s List, and subsequently in DVDs/films worldwide. It is also now used extensively in consumer products worldwide, including the Samsung Galaxy and iPhone Smart phones as well as the iPad.

In 2002, he was awarded a CBE for his contributions to engineering and higher education.

He has published five research books, 380 peer-reviewed research papers and holds over 20 patents. He is currently Director of the Institute of Electronics, Communications and Information Technology (ECIT) at Queen’s University Belfast. From 2005 to 2010, he was also Head of the School of Electronics, Electrical Engineering and Computer Science at Queen’s.

He was responsible within Queen’s University for developing the vision that led to the creation of the Northern Ireland Science Park and in 2004, the creation of its £37M research flagship, ECIT. The Science Park today hosts over 120 companies and employs over 2100 people. He also led the initiative that created the £30M UK Centre for Secure Information Technology (CSIT). CSIT now has over 80 people working in the field of cybersecurity and related technologies and is an EPSRC/InnovateUK/InvestNI-funded Innovation and Knowledge Centre based at ECIT. CSIT has helped create over 900 new jobs in cybersecurity in the Belfast area alone in the past two years. Professor McCanny is currently chairing the Royal Society’s policy committee on cyber security research in the UK. He holds a bachelor's degree in Physics from the University of Manchester, a PhD in Physics from the University of Ulster and was awarded a DSc in 1998 in Electrical and Electronics Engineering by Queen’s University Belfast.

back to top 

Professor Sir Jim McDonald FREng FRSE

Professor Sir Jim McDonald joined Strathclyde University in 1984, following six years in the UK electricity supply industry, having worked for SSEB and Scottish Hydro Electric. He was appointed to the Rolls-Royce Chair in Electrical Power Systems in 1993, and led research in advanced electrical power systems.  He became Head of Department in Electronic and Electrical Engineering in 2003, and acts as Chairman of Strathclyde’s Institute for Energy and Environment, the largest power engineering and energy systems research group internationally. He advises government, industry and commerce on the generation, transmission and distribution of electrical energy.

He was appointed Deputy Principal in 2006 to lead the University’s research and commercialisation portfolio.  He became Principal and Vice-Chancellor of the University of Strathclyde in March 2009.  He is Chairman of two of the Scottish research pools – multi-institutional consortia combining world-class research talent and facilities - these are: the Scottish Research Partnership in Engineering (SRPE); and, the Scottish Energy Technology Partnership (ETP), involving all energy research intensive Universities – the largest of its type in Europe.   

He has served on the Scottish Enterprise Board and as a member of the UK Trade and Investment Energy Excellence Board.  He co-chairs - with the First Minister - the Scottish Government’s Energy Advisory Board. He is Chairman of the independent Glasgow Economic Leadership Board for the City of Glasgow and, in 2011, was appointed as Chairman of the Board of the Glasgow Science Centre.  In October 2012, he was appointed as Vice-President of the UK’s Institution of Engineering and Technology (IET) and, in April 2014, became Honorary President of IET Scotland.

In January 2013, he was appointed as Non-Executive Director of the UK Offshore Renewable Energy Catapult Board. He became an Independent Director of Scottish Power Energy Networks Holdings in March 2014.  In January 2015, he was appointed as Non-Executive Director of the Weir Group.

In the Queen’s Jubilee Birthday Honours List on 16 June 2012, Professor McDonald was awarded a Knighthood for services to education, engineering and the economy.   In September 2013 Professor McDonald received the “Outstanding Contribution as a Business Leader”, recognition at The Herald’s Inaugural Inspiring City Awards event.

Jim is a fellow of the Royal Academy of Engineering, The Royal Society of Edinburgh, The Institution of Engineering and Technology, The Institute of Physics and The Energy Institute.

back to top

Dr Ruth McKernan CBE

Dr Ruth McKernan stood down from the Dowling Review Group on 1 May 2015, when she took up her post as CEO of Innovate UK

Ruth McKernan is Senior Vice President of Pfizer and Chief Scientific Officer at Neusentis, Pfizer‘s research units in Cambridge, UK and Durham, US. Born in Scotland, she gained her BSc in Pharmacology and Biochemistry at King's College London and her PhD at London University’s Institute of Psychiatry, studying the mechanism of action of antidepressant drugs. After two years on a Fulbright Scholarship at the University of California in San Diego, she joined the pharmaceutical Industry.

Ruth spent 17 years at Merck, becoming Head of the Merck Neuroscience Research Centre in Harlow in the UK in 2001. She joined Pfizer in 2005 as Vice President of Biology in Sandwich. Since then she has been Head of the Research Technology Centre in Boston and in 2008 she started Pfizer Regenerative Medicine, a new area of innovation for the company. In 2010 she was additionally appointed as Head of the Sandwich Site with over 2000 staff.  In April 2011, she formed the new Cambridge Research Unit, Neusentis. 

Ruth contributes broadly to further science outside of Pfizer. She has worked extensively with the Technology Strategy Board in the area of innovation, particularly relating to stem cells, and was the interim co-chair of the Cell Therapy Catapult Centre. Ruth sits on the Board of Pfizer, UK, and has been on the advisory Board of several biotech companies and the Canadian Centre for Regenerative Medicine. She is also a member of the Medical Research Council, sits on the Cancer Research Technology Board, and is a visiting Professor for King’s College, London.

Scientifically, Ruth is best known for her research in neuroscience on ligand-gated ion channels with over 130 publications and 15 patents. She has also won awards for science writing and her first book for non-scientists, Billy’s Halo, was short-listed for the 2007 MIND awards. She was awarded a CBE for services to business and innovation in 2013.

back to top

Professor Ric Parker CBE FREng

Richard (Ric) Parker was appointed Director of Research and Technology, Rolls-Royce Group in January 2001, and is based in Derby, United Kingdom. He is responsible for direction and co-ordination of Research and Technology programmes across all the Rolls-Royce businesses worldwide. Ric was announced as European CTO (Chief Technology Officer) of the Year in 2014.

Ric joined Rolls-Royce in 1978, and has held various posts including Chief of Composites and Ceramics, Chief of Compressor Engineering, Managing Director Compressor Systems and Director of Engineering and Technology, Civil Aerospace.

Ric was awarded a CBE in the 2013 New Year’s Honours List for services to engineering. Ric is a Fellow of the Royal Academy of Engineering, a Fellow of the Royal Aeronautical Society, a Fellow of the Institute of Physics and a Fellow of the Institution of Mechanical Engineers. He is a Liveryman in the Worshipful Company of Engineers.

Ric gained a BSc in Physics at Imperial College, London in 1975 and an MBA with distinction at Loughborough University in 1992. He has Doctorates (honoris causa) from Pusan National University, Korea and Nanyang Technological University, Singapore; and from Loughborough University, Sheffield University and Heriot Watt University, in the UK. He is a visiting Professor in Aerospace and Transport Technology at Loughborough University and an Honorary Professor in Materials Engineering at Birmingham University, UK.

Ric is married to Jenette, has two daughters, and lives in Littleover, Derby, UK

back to top 

Mr Nigel Perry FREng

Nigel is a Chartered Engineer with 30 years of experience in the global process industry. He spent over 20 years with ICI, enjoying an international career in engineering, operations, technology management, and project and business management, gaining experience in Asia, Europe and the US.

From ICI he joined PwC Consulting focusing on the development, consolidation and evolution of the European High Technology Sector including the adoption and emergence of new technologies, and new business models and new entrants.

He was appointed a director and Chief Executive Officer of the Centre for Process Innovation in 2003. He has taken the company from startup, to today where it employs over 200 high-calibre scientists and engineers and is recognised internationally as a world-class resource supporting the process industry in sustainable processing, industrial biotechnology and printable electronics. The company is widely viewed as an exemplar of the public and private sectors working together to establish innovation supply chains in new technologies, a vital competence much needed in the UK which has been recognised by theCPI becoming part of the government's first elite High Value Manufacturing Catapult.

He is a Fellow and past Technical Vice President of the Institution of Chemical Engineers and is also a Fellow of the Institution of Engineering and Technology.

He has an MA in Engineering Science from the University of Oxford, and is an alumnus of the Accelerated Development Programme at London Business School and the Entrepreneurship Development Program at MIT. He is a Visiting Professor at Newcastle University.

He was elected as a Fellow of the Royal Academy of Engineering in 2010.

back to top 

Dr Mark Taylor

Mark is Global Strategy and Research Director for Dyson – an international technology company. Dyson has an annual turnover of £1.2bn and produces machines across three product categories: floorcare, environmental control and hand drying.

Mark leads Dyson’s partnerships with 15 different universities in the UK – encompassing more than 50 different research projects and 90 university research heads. Prominent collaborations include the Dyson Robotics Laboratory at Imperial College London, and work with the University of Cambridge on fluid dynamics.

Mark has been with Dyson for the last 15 years. Prior to his current role he was Global R&D Operations Director, leading a team of 1,800 engineers and scientists across the UK, Singapore and Malaysia. Before joining Dyson, Mark worked for BOC Edwards as a Development Engineer.

Mark holds undergraduate and master’s degrees in chemistry from Bristol University. He also holds a PhD in inorganic chemistry from the university, specialising in the vacuum deposition of novel, thin-film chemistries to improve semiconductor manufacture and performance.

back to top 

Professor Jeremy Watson CBE FREng

Jeremy Watson CBE FREng FIET FICE is Professor in the Department of Science, Technology, Engineering and Public Policy with responsibility, as Vice-Dean, for engineering mission at UCL. Concurrently, he holds the post of Chief Scientist and Engineer at BRE. Jeremy was previously Arup’s Global Research Director, and until November 2012, Chief Scientific Advisor for the Department of Communities and Local Government (DCLG). An electrical engineer by training and practice, he has experience of research and technical direction in industry and universities, also governing board membership at TSB and EPSRC, plus service with NERC and HEFCE. He has recently served on two government SAGE panels (Flooding and Pandemics) and a Blackett Review. His specialities include research strategy, innovation eco-systems and processes, emerging technology identification, R&D and technology deployment. Jeremy is Deputy President of the IET.

back to top